Skip to main content

Curaleaf Holdings, Inc.

CURLF
Exchange
OTC
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001756770

No open-market purchases or sales by Curaleaf Holdings, Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $134.7M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Curaleaf Holdings, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of CURLF: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders15116+2
Shares308.3K1.40K226.5K−80.4K (−26.2%)
Value$4.35M$20.0K$2.73M−$1.60M (−36.9%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Curaleaf Holdings, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CURLF in Q3 2021
InstitutionSharesValue% of portfolio
Albert D Mason Inc30,066$362.0K0.23%
Canton Hathaway, LLC5,500$67.0K0.02%
Gilder Gagnon Howe & Co LLC2,188$27.0K0.00%
AlphaMark Advisors, LLC2,000$24.0K0.01%
Navigation Wealth Management, Inc.76$1.00K0.01%

Sold out (3)

Institutions that held Curaleaf Holdings, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of CURLF in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Wesbanco Bank Inc133,649$1.88M
Flagship Private Wealth, LLC150$2.08K
McCarthy Asset Management, Inc.100$1.00K

Not filed for Q3 2021 yet (1)

Institutions that held Curaleaf Holdings, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CURLF in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Castleview Partners, LLC1,400$20.0K